Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Tumor Lymphatic Function Regulates Tumor Inflammatory and Immunosuppressive Microenvironments.

Kataru RP, Ly CL, Shin J, Park HJ, Baik JE, Rehal S, Ortega S, Lyden D, Mehrara BJ.

Cancer Immunol Res. 2019 Aug;7(8):1345-1358. doi: 10.1158/2326-6066.CIR-18-0337. Epub 2019 Jun 11.

PMID:
31186247
2.

Fibrosis and secondary lymphedema: chicken or egg?

Kataru RP, Wiser I, Baik JE, Park HJ, Rehal S, Shin JY, Mehrara BJ.

Transl Res. 2019 Jul;209:68-76. doi: 10.1016/j.trsl.2019.04.001. Epub 2019 Apr 4. Review.

PMID:
31022376
3.

Regulation of Immune Function by the Lymphatic System in Lymphedema.

Kataru RP, Baik JE, Park HJ, Wiser I, Rehal S, Shin JY, Mehrara BJ.

Front Immunol. 2019 Mar 18;10:470. doi: 10.3389/fimmu.2019.00470. eCollection 2019. Review.

4.

T helper 2 differentiation is necessary for development of lymphedema.

Ly CL, Nores GDG, Kataru RP, Mehrara BJ.

Transl Res. 2019 Apr;206:57-70. doi: 10.1016/j.trsl.2018.12.003. Epub 2018 Dec 21.

PMID:
30633890
5.

Small Numbers of CD4+ T Cells Can Induce Development of Lymphedema.

Ly CL, Cuzzone DA, Kataru RP, Mehrara BJ.

Plast Reconstr Surg. 2019 Mar;143(3):518e-526e. doi: 10.1097/PRS.0000000000005322.

PMID:
30601329
6.

Baseline Lymphatic Dysfunction Amplifies the Negative Effects of Lymphatic Injury.

Hespe GE, Ly CL, Kataru RP, Mehrara BJ.

Plast Reconstr Surg. 2019 Jan;143(1):77e-87e. doi: 10.1097/PRS.0000000000005091.

PMID:
30589786
7.

CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema.

García Nores GD, Ly CL, Cuzzone DA, Kataru RP, Hespe GE, Torrisi JS, Huang JJ, Gardenier JC, Savetsky IL, Nitti MD, Yu JZ, Rehal S, Mehrara BJ.

Nat Commun. 2018 May 17;9(1):1970. doi: 10.1038/s41467-018-04418-y.

8.

Regulatory T Cells Mediate Local Immunosuppression in Lymphedema.

García Nores GD, Ly CL, Savetsky IL, Kataru RP, Ghanta S, Hespe GE, Rockson SG, Mehrara BJ.

J Invest Dermatol. 2018 Feb;138(2):325-335. doi: 10.1016/j.jid.2017.09.011. Epub 2017 Sep 20.

9.

Lymphedema: Pathogenesis and Novel Therapies.

Dayan JH, Ly CL, Kataru RP, Mehrara BJ.

Annu Rev Med. 2018 Jan 29;69:263-276. doi: 10.1146/annurev-med-060116-022900. Epub 2017 Sep 6. Review.

PMID:
28877002
10.

Topical tacrolimus for the treatment of secondary lymphedema.

Gardenier JC, Kataru RP, Hespe GE, Savetsky IL, Torrisi JS, Nores GD, Jowhar DK, Nitti MD, Schofield RC, Carlow DC, Mehrara BJ.

Nat Commun. 2017 Feb 10;8:14345. doi: 10.1038/ncomms14345.

11.

Inflammatory Manifestations of Lymphedema.

Ly CL, Kataru RP, Mehrara BJ.

Int J Mol Sci. 2017 Jan 17;18(1). pii: E171. doi: 10.3390/ijms18010171. Review.

12.

Lymph Node Transplantation Decreases Swelling and Restores Immune Responses in a Transgenic Model of Lymphedema.

Huang JJ, Gardenier JC, Hespe GE, García Nores GD, Kataru RP, Ly CL, Martínez-Corral I, Ortega S, Mehrara BJ.

PLoS One. 2016 Dec 12;11(12):e0168259. doi: 10.1371/journal.pone.0168259. eCollection 2016.

13.

Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.

Gardenier JC, Hespe GE, Kataru RP, Savetsky IL, Torrisi JS, Nores GDG, Dayan JJ, Chang D, Zampell J, Martínez-Corral I, Ortega S, Mehrara BJ.

JCI Insight. 2016 Sep 22;1(15):e84095. doi: 10.1172/jci.insight.84095.

14.

Obesity-induced lymphatic dysfunction is reversible with weight loss.

Nitti MD, Hespe GE, Kataru RP, García Nores GD, Savetsky IL, Torrisi JS, Gardenier JC, Dannenberg AJ, Mehrara BJ.

J Physiol. 2016 Dec 1;594(23):7073-7087. doi: 10.1113/JP273061. Epub 2016 Oct 9.

15.

Obesity but not high-fat diet impairs lymphatic function.

García Nores GD, Cuzzone DA, Albano NJ, Hespe GE, Kataru RP, Torrisi JS, Gardenier JC, Savetsky IL, Aschen SZ, Nitti MD, Mehrara BJ.

Int J Obes (Lond). 2016 Oct;40(10):1582-1590. doi: 10.1038/ijo.2016.96. Epub 2016 May 20.

16.

Exercise training improves obesity-related lymphatic dysfunction.

Hespe GE, Kataru RP, Savetsky IL, García Nores GD, Torrisi JS, Nitti MD, Gardenier JC, Zhou J, Yu JZ, Jones LW, Mehrara BJ.

J Physiol. 2016 Aug 1;594(15):4267-82. doi: 10.1113/JP271757. Epub 2016 Apr 9.

17.

Inhibition of Inflammation and iNOS Improves Lymphatic Function in Obesity.

Torrisi JS, Hespe GE, Cuzzone DA, Savetsky IL, Nitti MD, Gardenier JC, García Nores GD, Jowhar D, Kataru RP, Mehrara BJ.

Sci Rep. 2016 Jan 22;6:19817. doi: 10.1038/srep19817.

18.

Lymphatic Function Regulates Contact Hypersensitivity Dermatitis in Obesity.

Savetsky IL, Albano NJ, Cuzzone DA, Gardenier JC, Torrisi JS, García Nores GD, Nitti MD, Hespe GE, Nelson TS, Kataru RP, Dixon JB, Mehrara BJ.

J Invest Dermatol. 2015 Nov;135(11):2742-2752. doi: 10.1038/jid.2015.283. Epub 2015 Jul 15.

19.

Th2 cytokines inhibit lymphangiogenesis.

Savetsky IL, Ghanta S, Gardenier JC, Torrisi JS, García Nores GD, Hespe GE, Nitti MD, Kataru RP, Mehrara BJ.

PLoS One. 2015 Jun 3;10(6):e0126908. doi: 10.1371/journal.pone.0126908. eCollection 2015.

20.

TH2 cells and their cytokines regulate formation and function of lymphatic vessels.

Shin K, Kataru RP, Park HJ, Kwon BI, Kim TW, Hong YK, Lee SH.

Nat Commun. 2015 Feb 4;6:6196. doi: 10.1038/ncomms7196.

PMID:
25648335
21.

Inflammation-associated lymphangiogenesis: a double-edged sword?

Kim H, Kataru RP, Koh GY.

J Clin Invest. 2014 Mar;124(3):936-42. doi: 10.1172/JCI71607. Epub 2014 Mar 3. Review.

22.

Interactions of immune cells and lymphatic vessels.

Kataru RP, Lee YG, Koh GY.

Adv Anat Embryol Cell Biol. 2014;214:107-18. doi: 10.1007/978-3-7091-1646-3_9. Review.

PMID:
24276890
23.

Regulation and implications of inflammatory lymphangiogenesis.

Kim H, Kataru RP, Koh GY.

Trends Immunol. 2012 Jul;33(7):350-6. doi: 10.1016/j.it.2012.03.006. Epub 2012 May 12. Review.

PMID:
22579522
24.

T lymphocytes negatively regulate lymph node lymphatic vessel formation.

Kataru RP, Kim H, Jang C, Choi DK, Koh BI, Kim M, Gollamudi S, Kim YK, Lee SH, Koh GY.

Immunity. 2011 Jan 28;34(1):96-107. doi: 10.1016/j.immuni.2010.12.016. Epub 2011 Jan 20.

25.

Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm.

Kim KE, Koh YJ, Jeon BH, Jang C, Han J, Kataru RP, Schwendener RA, Kim JM, Koh GY.

Am J Pathol. 2009 Oct;175(4):1733-45. doi: 10.2353/ajpath.2009.090133. Epub 2009 Sep 17.

26.

Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution.

Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, Han SH, Alitalo K, Koh GY.

Blood. 2009 May 28;113(22):5650-9. doi: 10.1182/blood-2008-09-176776. Epub 2009 Apr 3.

27.

Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.

Jeon BH, Jang C, Han J, Kataru RP, Piao L, Jung K, Cha HJ, Schwendener RA, Jang KY, Kim KS, Alitalo K, Koh GY.

Cancer Res. 2008 Feb 15;68(4):1100-9. doi: 10.1158/0008-5472.CAN-07-2572.

Supplemental Content

Loading ...
Support Center